HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.

Abstract
Several investigators have reported an altered platelet function in diabetes mellitus as measured by elevated levels of platelet specific proteins platelet factor 4 (PF4) and B-thromboglobulin (BTG). We studied 20 insulin dependent (IDD), 20 non insulin dependent (NIDD) diabetic males without overt clinical symptoms of cardiovascular disorders and 30 normal controls. We evaluated PF4, BTG and heparin released platelet factor 4 (HR-PF4) as measured 2.5 minutes after a bolus injection of 5,000 I.U. of a commercial mucous heparin. The patients showed normal levels of both PF4 and BTG. Furthermore HR-PF4 failed to show statistically significant variation between patients and controls. However when the diabetics were divided on the basis of the duration of the disease, the IDD had an increased HR-PF4 mean level and the trend became statistically significant when diabetes existed more than 17 years (patients HR-PF4 149.1 ng/ml, range 17.3-194; controls HR-PF4 110.9 ng/ml range 50-160, less than p less than 0.05). NIDD failed to reveal the same pattern. Although the significance of HR-PF4 is unknown, insulin dependent diabetes mellitus after many years could cause a potentially dangerous, silent vascular damage with enhanced platelet vessel wall interaction as measured by an elevated HR-PF4.
AuthorsG Cella, N Scattolo, C Vio, F Stevanato, T Lavagnini, D Padovan, A Girolami
JournalFolia haematologica (Leipzig, Germany : 1928) (Folia Haematol Int Mag Klin Morphol Blutforsch) Vol. 113 Issue 5 Pg. 646-54 ( 1986) ISSN: 0323-4347 [Print] GERMANY, EAST
PMID2435630 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • beta-Thromboglobulin
  • Platelet Factor 4
  • Heparin
Topics
  • Adolescent
  • Adult
  • Diabetes Mellitus, Type 1 (blood)
  • Diabetes Mellitus, Type 2 (blood)
  • Female
  • Heparin (pharmacology)
  • Humans
  • Male
  • Middle Aged
  • Platelet Factor 4 (analysis, metabolism)
  • Reference Values
  • Vascular Diseases (blood)
  • beta-Thromboglobulin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: